The cost of naloxone has spiraled upwards, even as the drug has become more desperately needed to reverse overdoses. » Read More
If implemented, Clinton's plan would increase the number of Americans insured while Trump's would not. » Read More
John Nelson, Lloyd's of London chairman, discusses the specialist insurance company's latest results and says market conditions are challenging.
Mylan also faces heat from multiple regulatory and legal agencies over huge cost increases for the anti-allergy auto-injectors.
Start-ups, such as Lemonade and Teambrella, are using peer-to-peer strategies to disrupt to the trillion-dollar insurance industry.
Mylan CEO Heather Bresch is set to testify Wednesday before a House committee over sky-high price hikes for lifesaving EpiPens.
Senate Finance Committee on Tuesday said it asked the Department of Health to investigate the rebates to state Medicaid programs for Mylan's EpiPen treatment.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
ICICI Bank CEO Chanda Kochhar says the listing of ICICI Prudential life Insurance is huge leap forward for India's capital markets and financial sector.
Despite rising Obamacare prices, the total premiums paid in many cases are less than work-based coverage.
Drugmakers need to learn empathy and not try to defend price hikes that make drugs inaccessible, GSK CEO Andrew Witty told CNBC.
CNBC's David Faber reports the latest on the merger between Anthem and Cigna.
Lloyd's of London Chairman John Nelson explains that the insurer remains competitive because of its specialties and relevant new products.
Roger Crandall, MassMutual CEO, talks about implementing technology into the company's growth strategies.
Roger Crandall, MassMutual CEO, discusses how his company is able to thrive in a low interest rate environment.
Workers are being forced to pay more out of pocket for health care than in the past.
The Republican presidential nominee plans to fund his program by eliminating fraud in unemployment insurance.
Opening arguments began on Tuesday in the trial of Maurice "Hank" Greenberg over accounting fraud at the insurance giant some 16 years ago.
Get the best of CNBC in your inbox